Free Trial

Envista (NYSE:NVST) Updates FY 2026 Earnings Guidance

Envista logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Envista updated its FY 2026 EPS guidance to 1.350–1.450, roughly in line with the Street consensus of 1.410, and did not provide revenue guidance.
  • The company beat the most recent quarterly estimate, reporting $0.36 EPS versus the $0.31 consensus, and analysts expect about $1.40 EPS for the year.
  • Analyst coverage is mixed—several firms have raised price targets (e.g., Morgan Stanley to $21, JPMorgan to $26, Citigroup $29, Leerink $35)—but MarketBeat shows a consensus rating of Hold with an average target of $28.25.
  • MarketBeat previews top five stocks to own in June.

Envista (NYSE:NVST - Get Free Report) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 1.350-1.450 for the period, compared to the consensus earnings per share estimate of 1.410. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the company. Morgan Stanley increased their price target on Envista from $19.00 to $21.00 and gave the stock an "equal weight" rating in a research report on Friday, April 24th. Wall Street Zen raised Envista from a "buy" rating to a "strong-buy" rating in a research report on Monday, January 26th. JPMorgan Chase & Co. increased their price target on Envista from $22.00 to $26.00 and gave the stock a "neutral" rating in a research report on Friday, February 6th. Citigroup started coverage on Envista in a research report on Wednesday, April 15th. They set a "neutral" rating and a $29.00 price target on the stock. Finally, Leerink Partners set a $35.00 target price on Envista and gave the stock an "outperform" rating in a research note on Friday, February 6th. Six analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $28.25.

View Our Latest Report on Envista

Envista Price Performance

NYSE NVST traded up $0.95 on Wednesday, hitting $27.14. 4,927,117 shares of the company's stock were exchanged, compared to its average volume of 2,746,830. The stock has a 50-day moving average of $26.67 and a 200-day moving average of $23.98. The company has a current ratio of 2.38, a quick ratio of 2.04 and a debt-to-equity ratio of 0.47. Envista has a 52 week low of $16.33 and a 52 week high of $30.42. The stock has a market cap of $4.42 billion, a price-to-earnings ratio of 96.92, a P/E/G ratio of 1.76 and a beta of 0.92.

Envista (NYSE:NVST - Get Free Report) last released its earnings results on Wednesday, May 6th. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.31 by $0.05. Envista had a return on equity of 6.54% and a net margin of 1.73%.Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Analysts expect that Envista will post 1.4 earnings per share for the current year.

Insider Buying and Selling at Envista

In related news, SVP Mischa Reis sold 9,675 shares of the business's stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $30.00, for a total transaction of $290,250.00. Following the sale, the senior vice president owned 32,382 shares in the company, valued at $971,460. The trade was a 23.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.99% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Envista

A number of hedge funds and other institutional investors have recently bought and sold shares of NVST. Caitong International Asset Management Co. Ltd grew its position in Envista by 16,711.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company's stock worth $31,000 after acquiring an additional 1,504 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Envista by 73.1% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company's stock worth $44,000 after acquiring an additional 949 shares during the last quarter. UMB Bank n.a. grew its position in Envista by 46.1% during the 4th quarter. UMB Bank n.a. now owns 2,017 shares of the company's stock worth $44,000 after acquiring an additional 636 shares during the last quarter. EverSource Wealth Advisors LLC grew its position in Envista by 378.0% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company's stock worth $47,000 after acquiring an additional 1,909 shares during the last quarter. Finally, Quarry LP bought a new stake in Envista during the 3rd quarter worth $66,000.

About Envista

(Get Free Report)

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company's offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista's product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.

Featured Articles

Earnings History and Estimates for Envista (NYSE:NVST)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Envista Right Now?

Before you consider Envista, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.

While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines